Purpose Identification of preoperative risk factors associated with pulmonary complications may benefit high‐risk patients from more intense surveillance and earlier interventions in liver transplantation (LT). Our study aimed to identify risk factors for predicting pulmonary complications in LT patients. Materials and methods The discovery data set enrolled 208 patients who underwent orthotopic LT while the validation data set included 117 patients. Clinical data were collected from medical history retrospectively and risk factors were determined by logistic regression analyses. The pulmonary complication score (PCS‐LT) was established and validated for predicting pulmonary complications after LT. Results In the discovery data set, 47 (22.6%) participants experienced pulmonary complications following LT. Four independent risk factors for pulmonary complications were identified by multivariate logistic regression analysis, including preoperative abnormal pulmonary function (OR = 4.743, p < .001), elevated lymphocyte count (OR = 2.336, p = .027), hypoproteinemia (OR = 2.635, p = .030), and hypokalemia (OR = 5.257, p = .003), and PCS‐LT based on these factors was established. ROC analyses showed PCS‐LT could predict PC in both the discovery data set (area under curve [AUC] .752, 95% confidence interval [CI] .687–.809) and the validation data set (AUC .754, 95% CI, .666–.829). The PCS‐LT demonstrated superior predictive value (AUC .735, 95% CI, .703–.799) to APACHE II score (AUC .653, 95% CI, .599–.705) in the combined data set (p = .032). Meanwhile, PCS‐LT > 1 was used as the cut‐off value and has prognostic significance in LT patients. Conclusions The PCS‐LT score, consisting of abnormal pulmonary function, elevated lymphocyte count, hypoproteinemia, and hypokalemia, could predict pulmonary complications after LT.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.